Collectively, these pieces of evidence suggest that FAM83D may be involved in the FBXW7/NOTCH1 degradation pathway and therefore, may be explored as a molecular target for colorectal cancer diagnosis and treatment.63, 64. This evidence concerns the gene SACK1D and colorectal cancer.